Trademark: M 885375
Word
M
Device Descrption:
2 WAVY STRIPES INTERSECTING FORM LTR M
ID
885375
Trademark Type
Figurative
Status
Registered: Registered/protected
Application Date
09 August 2001
Registration Date
09 August 2001
Renewal Date
09 August 2031
Service
Davies Collison Cave Pty Ltd
Goods and Services:
Class 1:
Diagnostic assays and test kits for laboratory and chemical use, including for providing genomic and proteomic profiles useful in the selection of therapeutics; prognostic test kits for identifying hereditary risk factors
Diagnostic assays and test kits for laboratory and chemical use, including for providing genomic and proteomic profiles useful in the selection of therapeutics; prognostic test kits for identifying hereditary risk factors
Class 5:
Prescription pharmaceutical preparations for use in the diagnosis or treatment of human diseases and disorders, including, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral urinary, renal, infectious, metabolic or central nervous system diseases and disorders, excluding analgesics; diagnostic assays and test kits for clinical and medical use to diagnose, prognose, predict or treat diseases; assays and test kits for evaluating efficacy of treatments and treatment progress; diagnostic preparations, including, preparations of extracts, assays, nucleic acids, proteins, polypeptides, and antibodies, and molecular arrays of biological materials for clinical or medical laboratory use
Prescription pharmaceutical preparations for use in the diagnosis or treatment of human diseases and disorders, including, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral urinary, renal, infectious, metabolic or central nervous system diseases and disorders, excluding analgesics; diagnostic assays and test kits for clinical and medical use to diagnose, prognose, predict or treat diseases; assays and test kits for evaluating efficacy of treatments and treatment progress; diagnostic preparations, including, preparations of extracts, assays, nucleic acids, proteins, polypeptides, and antibodies, and molecular arrays of biological materials for clinical or medical laboratory use
Class 42:
Medical and diagnostic services, including, diagnosing, preventing, and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; research services, including, research, development, validation, testing, data analysis and product development services in the biomedical, genomic pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; research consulting services, including, research, development, validation, testing, data analysis, and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomics, diagnostic, clinical trial design, and biotechnology fields; computer services, including, providing access to databases of life sciences information via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology; computer consulting services, including, providing access to databases of life sciences information to others via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology
Medical and diagnostic services, including, diagnosing, preventing, and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; research services, including, research, development, validation, testing, data analysis and product development services in the biomedical, genomic pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; research consulting services, including, research, development, validation, testing, data analysis, and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomics, diagnostic, clinical trial design, and biotechnology fields; computer services, including, providing access to databases of life sciences information via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology; computer consulting services, including, providing access to databases of life sciences information to others via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology